The United States is currently facing a growing concern over a deadly fungus that is rapidly spreading in healthcare facilities.
The Centers for Disease Control and Prevention (CDC) has identified the fungus as “Candida Auris,” also known as “C.
auris,” which is a type of yeast that can cause serious illness in immunocompromised individuals such as cancer patients.
The fungus is difficult to diagnose as its symptoms are similar to fever and chills, and it often gets misdiagnosed.
According to Dr.
John Bradley, the medical director of infectious diseases at Rady Children’s hospital, healthy individuals with a reasonable immune system are unlikely to die from the fungus.
However, for those who are immunocompromised, the fungus can be life-threatening.
The CDC is concerned about the rapid spread of Candida Auris across the country, which is faster than expected.
As of this year, there have been 20 reported cases of the fungus, down from last year’s 60 cases.
Bradley emphasized that hospitals are now prepared to deal with the fungus, and doctors have treatment options available, although Candida Auris is resistant to some anti-fungal drugs, and heavier doses can cause more side effects.
Healthcare workers can potentially spread the fungus from one patient to another if they don’t wash their hands.
Although the fungus is concerning, Dr.
Bradley noted that it is not nearly as contagious as COVID-19.
Candida Auris is not airborne, and individuals cannot contract the fungus by talking to someone.
Instead, it is spread through touching surfaces or mucous membranes.
In conclusion, healthcare facilities across the United States need to be aware of the risks posed by Candida Auris and take necessary precautions to prevent its spread.
More testing is required to identify cases early, and hospitals should prepare to deal with the fungus promptly.